UROVIST CYSTO PEDIATRIC Drug Patent Profile
✉ Email this page to a colleague
When do Urovist Cysto Pediatric patents expire, and what generic alternatives are available?
Urovist Cysto Pediatric is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in UROVIST CYSTO PEDIATRIC is diatrizoate meglumine. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for UROVIST CYSTO PEDIATRIC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 890 |
Formulation / Manufacturing: | see details |
DailyMed Link: | UROVIST CYSTO PEDIATRIC at DailyMed |
US Patents and Regulatory Information for UROVIST CYSTO PEDIATRIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | UROVIST CYSTO PEDIATRIC | diatrizoate meglumine | SOLUTION;URETERAL | 087731-001 | Sep 23, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |